CroíValve
Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease
$27MSeries B
Role not disclosedEI
European Innovation Council (EIC)
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $144.9M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionButterfly Medical
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men
$21MSeries C
Role not disclosedFineHeart
Develops cardiology devices, including the fully implantable FlowMaker system.
€83MSeries C
Role not disclosed